These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 30539254)

  • 21. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
    Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
    Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update.
    Kaur A; Wilhelm M; Wilk S; Hirsch HH
    Curr Opin Infect Dis; 2019 Dec; 32(6):575-583. PubMed ID: 31567736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Polyoma virus BK nephropathy in kidney allograft recipients].
    Matłosz B; Durlik M
    Przegl Epidemiol; 2006; 60(1):133-40. PubMed ID: 16758752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
    Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
    Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
    Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
    Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.
    Dieplinger G; Everly MJ; Briley KP; Haisch CE; Bolin P; Maldonado AQ; Kendrick WT; Kendrick SA; Morgan C; Terasaki PI; Rebellato LM
    Transpl Infect Dis; 2015 Dec; 17(6):848-58. PubMed ID: 26442607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.
    Bischof N; Hirsch HH; Wehmeier C; Amico P; Dickenmann M; Hirt-Minkowski P; Steiger J; Menter T; Helmut H; Schaub S
    Nephrol Dial Transplant; 2019 Jul; 34(7):1240-1250. PubMed ID: 30476254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BK polyomavirus viremia and antibody responses of pediatric kidney transplant recipients in Finland.
    Miettinen J; Lautenschlager I; Weissbach F; Wernli M; Auvinen E; Mannonen L; Lauronen J; Hirsch HH; Jalanko H
    Pediatr Transplant; 2019 Feb; 23(1):e13324. PubMed ID: 30447046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunophenotyping of different stages of BK virus allograft nephropathy.
    Li P; Cheng D; Wen J; Ni X; Li X; Xie K; Chen J
    Ren Fail; 2019 Nov; 41(1):855-861. PubMed ID: 31535918
    [No Abstract]   [Full Text] [Related]  

  • 31. Virus-specific T cells in pediatric renal transplantation.
    Ahlenstiel-Grunow T; Pape L
    Pediatr Nephrol; 2021 Apr; 36(4):789-796. PubMed ID: 32221706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
    Jaw J; Hill P; Goodman D
    Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
    Korth J; Anastasiou OE; Verheyen J; Dickow J; Sertznig H; Frericks N; Bleekmann B; Kribben A; Brinkhoff A; Wilde B; Sutter K; Dittmer U; Ciesek S; Witzke O; Widera M
    Antiviral Res; 2018 Nov; 159():68-76. PubMed ID: 30268912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Hirsch HH; Randhawa PS;
    Clin Transplant; 2019 Sep; 33(9):e13528. PubMed ID: 30859620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of BK viremia by urine viral load in renal transplant patients: An analysis of BK viral load results in paired urine and plasma samples.
    Madden K; Janitell C; Sower D; Yang S
    Transpl Infect Dis; 2018 Oct; 20(5):e12952. PubMed ID: 29896858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic Clearance of a BK Virus-associated Metastatic Renal Allograft Carcinoma.
    Meier RPH; Muller YD; Dietrich PY; Tille JC; Nikolaev S; Sartori A; Labidi-Galy I; Ernandez T; Kaur A; Hirsch HH; McKee TA; Toso C; Villard J; Berney T
    Transplantation; 2021 Feb; 105(2):423-429. PubMed ID: 32091486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
    Al-Raisi F; Mohsin N; Kamble P
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
    Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
    Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
    van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
    J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.